Objectives of the ABE Core The ABE Core oversees all aspects of Mid-Atlantic NORC function. The ABE Core is responsible for the promotion of interactions and collaborations among Center investigators, oversight of Core utilization, programmatic and cost-effectiveness of Core services, administration of the P/F grants program, communication of Mid-Atlantic NORC activities and Core functions to its members, and implementation of the Enrichment Program. The Biostatistics and Medical Informatics (BMI) Subcore resides within the ABE Core and provides statistical and database support to all investigators. The Core, through its Program Coordinator, provides administrative support for a list-serve, website development and maintenance, organization of internal and external advisory committees, and submission of progress reports and related grant proposals (e.g., equipment grants), and maintenance of records for core usage, IRB approval status and Data Safety Monitoring. It also maintains lists and copies of publications that cite Center support. Importantly, the ABE Core is responsible for long-range planning, including the setting of Core priorities to meet the needs of Center investigators and the evolving challenges of multidisciplinary nutrition and obesity research. Dr. Shuldiner directs the ABE Core and Dr. Goldberg serves as Co-Director. Other members of the ABE Core leadership are Dr. Nanette Steinle (Director of the Enrichment Program), Dr. John Sorkin (Director ofthe BMI Subcore), and Gabriele Ronnett (Co-Director of the P/F Program).

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK072488-10
Application #
8733156
Study Section
Special Emphasis Panel (ZDK1-GRB-2)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
10
Fiscal Year
2014
Total Cost
$186,643
Indirect Cost
$57,998
Name
University of Maryland Baltimore
Department
Type
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Lent, Michelle R; Benotti, Peter N; Wood, G Craig (2018) Response to comment on Lent et al. All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes. Diabetes Care 2017;40:1379-1385. Diabetes Care 41:e20
Spanakis, Elias K; Levitt, David L; Siddiqui, Tariq et al. (2018) The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System. J Diabetes Sci Technol 12:20-25
Montasser, May E; O'Hare, Elizabeth A; Wang, Xiaochun et al. (2018) An APOO Pseudogene on Chromosome 5q Is Associated With Low-Density Lipoprotein Cholesterol Levels. Circulation 138:1343-1355
Taylor, Simeon I (2018) GLP-1 receptor agonists: differentiation within the class. Lancet Diabetes Endocrinol 6:83-85
Blau, Jenny E; Bauman, Viviana; Conway, Ellen M et al. (2018) Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study. JCI Insight 3:
Geng, Xin; Irvin, Marguerite R; Hidalgo, Bertha et al. (2018) An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort. J Lipid Res 59:722-729
Ryan, Alice S; Serra, Monica C; Goldberg, Andrew P (2018) Metabolic Benefits of Prior Weight Loss with and without Exercise on Subsequent 6-Month Weight Regain. Obesity (Silver Spring) 26:37-44
Mitchell, Braxton D; Kalra, Gurmannat; Ryan, Kathleen A et al. (2018) Increased usual physical activity is associated with a blunting of the triglyceride response to a high-fat meal. J Clin Lipidol :
Differding, Moira K; Mueller, Noel T (2018) Are household disinfectants microbially mediated obesogens? CMAJ 190:E1095-E1096
Blau, Jenny E; Taylor, Simeon I (2018) Adverse effects of SGLT2 inhibitors on bone health. Nat Rev Nephrol 14:473-474

Showing the most recent 10 out of 488 publications